DIA 2020 Virtual Global Annual Meeting

Component Type: Session
Level: Intermediate

Initiating a clinical trial is a lengthy process, complicated by multiple stakeholders, inaccurate data and complex protocols. The budget creation and negotiation lifecycle today relies on manual, time-consuming workflows which leads to delays. Transforming these processes for clinical trial sponsors and CROs is critical; enabling efficiency and data accuracy can support a streamlined and optimized study start-up, resulting in speed to market, and the delivery of potentially life-saving products to patients that need them. Today, increased focus has been placed on optimizing elements of study initiation using effective technology - driving process improvement, enhanced collaboration and leveraging reliable sources of data. In this session, you will discover how to transform your study start up processes, from site selection, contracting to budget negotiation. These steps will help to provide complete confidence in your clinical trial initiation, providing for transparency and management of rates and approvals, ultimately ensuring that your clinical trial is ready for the first patient in.

Learning Objectives

Discuss how to influence future budget negotiation processes from sponsor and CRO to sites to increase financial transparency and predictability; Evaluate key data points needed to estimate overall clinical trial study costs from start up to completion; Identify time-saving efficiencies in study design and start up using integrated workflows and technology resulting in speed to market.

Chair

Jim Murphy, MS

Speaker

Contracting as Critical Element Before Start of a Clinical Trial: General Approaches and Examples for Possible Solutions
Thorsten Ruppert, PharmD

Optimizing Site Selection for a Global Clinical Trial
Vladimir Shnaydman, PhD